Vectura Group PLC Company Profile (LON:VEC)

About Vectura Group PLC (LON:VEC)

Vectura Group PLC logoVectura Group plc is engaged in research, development and commercialization of therapeutic products and drug delivery systems for human use. The Company's products include Ultibro Breezhaler (European Union (EU) and Rest of World (RoW)) - LABA-LAMA; Seebri Breezhaler (EU and RoW) - LAMA; AirFluSal Forspiro (EU and RoW) - ICS-LABA; ADVATE (Global) - Antihaemophilic Factor (Recombinant); Adept (Global) - Icodextrin; Anoro Ellipta (Global) - LAMA-LABA; Relvar Ellipta/Breo Ellipta (Global) - ICS-LABA, and Incruse Ellipta (Global) - LAMA. Its product pipeline includes VR588, VR475, VR647, VR942, VR179, VR736, VR096, VR876, VR315, VR506, VR632, Seebri Neohaler and VR465. Its dry powder inhalers (DPI) include GyroHaler, Lever-operated, Open-inhale-close and Unit Dose DPI. Its smart nebuliser delivery systems provide targeted inhalation therapy for applications where precise and targeted delivery of a drug to the lungs is needed. Its smart nebulizer delivery systems include AKITA JET and FOX.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Generic Pharmaceuticals
  • Sub-Industry: N/A
  • Symbol: LON:VEC
  • CUSIP: N/A
  • Web: www.vectura.com
Capitalization:
  • Market Cap: £678.5 million
  • Outstanding Shares: 678,500,000
Average Prices:
  • 50 Day Moving Avg: GBX 102.93
  • 200 Day Moving Avg: GBX 117.59
  • 52 Week Range: GBX 88.90 - GBX 166.97
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: £168.67 million
  • Price / Sales: 4.02
  • Book Value: GBX 0.96 per share
  • Price / Book: 1.04
Profitability:
  • EBITDA: £48.27 million
  • Net Margins: -48.35%
  • Return on Equity: -11.44%
  • Return on Assets: -9.24%
Misc:
  • Average Volume: 1.65 million shs.
 

Frequently Asked Questions for Vectura Group PLC (LON:VEC)

What is Vectura Group PLC's stock symbol?

Vectura Group PLC trades on the London Stock Exchange (LON) under the ticker symbol "VEC."

Where is Vectura Group PLC's stock going? Where will Vectura Group PLC's stock price be in 2017?

11 analysts have issued 12-month target prices for Vectura Group PLC's shares. Their forecasts range from GBX 160 to GBX 225. On average, they expect Vectura Group PLC's stock price to reach GBX 199.63 in the next year. View Analyst Ratings for Vectura Group PLC.

Who are some of Vectura Group PLC's key competitors?

Who are Vectura Group PLC's key executives?

Vectura Group PLC's management team includes the folowing people:

  • James Ward-Lilley, Chief Executive Officer, Executive Director
  • Frank C. Condella Jr., Vice Chairman of the Board
  • Andrew Derodra, Chief Financial Officer, Director
  • Joanne Hombal, Director of Human Resources
  • Roger Heerman, Chief Commercial Officer
  • Karl David Keegan Ph.D., Chief Corporate Development Officer
  • Bruno F. J. Angelici, Non-Executive Chairman of the Board
  • Per-Olof Andersson, Non-Executive Director
  • Thomas Werner, Non-Executive Director
  • Susan Elizabeth Foden Ph.D., Senior Independent Non-Executive Director

How do I buy Vectura Group PLC stock?

Shares of Vectura Group PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Vectura Group PLC's stock price today?

One share of Vectura Group PLC stock can currently be purchased for approximately GBX 100.


MarketBeat Community Rating for Vectura Group PLC (LON VEC)
Community Ranking:  4.1 out of 5 (star star star star)
Outperform Votes:  662 (Vote Outperform)
Underperform Votes:  140 (Vote Underperform)
Total Votes:  802
MarketBeat's community ratings are surveys of what our community members think about Vectura Group PLC and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Vectura Group PLC (LON:VEC) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Sell Rating, 2 Hold Ratings, 8 Buy Ratings
Consensus Rating:Buy (Score: 2.64)
Consensus Price Target: GBX 199.63
Consensus Price Target History for Vectura Group PLC (LON:VEC)
Price Target History for Vectura Group PLC (LON:VEC)
Analysts' Ratings History for Vectura Group PLC (LON:VEC)
Show:
DateFirmActionRatingPrice TargetDetails
10/5/2017Numis Securities LtdReiterated RatingBuyGBX 205View Rating Details
9/21/2017J P Morgan Chase & CoLower Price TargetOverweightGBX 210 -> GBX 180View Rating Details
9/18/2017Citigroup Inc.Lower Price TargetBuyGBX 200 -> GBX 180View Rating Details
9/6/2017Peel HuntReiterated RatingHoldGBX 160View Rating Details
8/30/2017Panmure GordonReiterated RatingBuyView Rating Details
8/16/2017Shore CapitalReiterated RatingBuyView Rating Details
6/29/2017N+1 SingerReiterated RatingHoldView Rating Details
4/25/2017Royal Bank Of CanadaDowngradeUnderperformView Rating Details
4/4/2017Stifel NicolausReiterated RatingBuyGBX 225View Rating Details
3/21/2017InvestecReiterated RatingBuyGBX 220View Rating Details
11/29/2016FinnCapReiterated RatingBuyGBX 225View Rating Details
(Data available from 10/20/2015 forward)

Earnings

Earnings History for Vectura Group PLC (LON:VEC)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Vectura Group PLC (LON:VEC)
Current Year EPS Consensus Estimate: $4.72 EPS

Dividends

Dividend History for Vectura Group PLC (LON:VEC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Vectura Group PLC (LON:VEC)
Insider Trades by Quarter for Vectura Group PLC (LON:VEC)
Insider Trades by Quarter for Vectura Group PLC (LON:VEC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/6/2017Andrew DerodraInsiderBuy142GBX 106£150.52
9/12/2017Bruno AngeliciInsiderBuy70,000GBX 99£69,300
9/8/2017Andrew DerodraInsiderBuy158GBX 94£148.52
9/7/2017Andrew DerodraInsiderBuy82,000GBX 90£73,800
8/4/2017Andrew DerodraInsiderBuy135GBX 111£149.85
6/6/2017Andrew DerodraInsiderBuy135GBX 111£149.85
5/5/2017Andrew DerodraInsiderBuy105GBX 143£150.15
4/6/2017Andrew DerodraInsiderBuy99GBX 152£150.48
2/6/2017Andrew DerodraInsiderBuy111GBX 135£149.85
9/30/2016Andrew DerodraInsiderBuy30,000GBX 138£41,400
9/27/2016Trevor PhillipsInsiderSell240,841GBX 139£334,768.99
9/26/2016Bruno AngeliciInsiderBuy80,000GBX 143£114,400
7/7/2016Derodra,AndrewInsiderSell263,364GBX 152£400,313.28
6/17/2016Derodra,AndrewInsiderSell419,661GBX 154£646,277.94
6/13/2016Derodra,AndrewInsiderSell279,774GBX 157£439,245.18
7/7/2015Oakley,Andrew J.InsiderBuy1,000GBX 180£1,800
1/15/2015Trevor PhillipsInsiderSell171,777GBX 144.50£248,217.77
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Vectura Group PLC (LON:VEC)
Latest Headlines for Vectura Group PLC (LON:VEC)
Source:
DateHeadline
americanbankingnews.com logoVectura Group PLC (VEC) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - October 11 at 10:32 PM
americanbankingnews.com logoInsider Buying: Vectura Group PLC (VEC) Insider Purchases 142 Shares of Stock
www.americanbankingnews.com - October 10 at 7:22 AM
americanbankingnews.com logoVectura Group PLC (VEC) Stock Rating Reaffirmed by Numis Securities Ltd
www.americanbankingnews.com - October 8 at 7:34 AM
americanbankingnews.com logoVectura Group PLC (VEC) PT Lowered to GBX 180 at J P Morgan Chase & Co
www.americanbankingnews.com - September 23 at 5:58 PM
finance.yahoo.com logoPulmatrix Receives Key Patents on its Inhaled Drug Delivery Technology and its COPD Drug
finance.yahoo.com - September 20 at 10:49 AM
americanbankingnews.com logoVectura Group PLC (VEC) Given New GBX 180 Price Target at Citigroup Inc.
www.americanbankingnews.com - September 18 at 3:54 PM
americanbankingnews.com logoVectura Group PLC (VEC) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - September 16 at 10:56 PM
lse.co.uk logoDIRECTOR DEALINGS: Vectura Chairman Buys 70000 Shares - London South East (registration) (blog)
www.lse.co.uk - September 13 at 3:47 PM
morningstar.co.uk logoDIRECTOR DEALINGS: Vectura Chairman Buys 70,000 Shares
www.morningstar.co.uk - September 13 at 10:55 AM
americanbankingnews.com logoBruno Angelici Purchases 70,000 Shares of Vectura Group PLC (VEC) Stock
www.americanbankingnews.com - September 13 at 7:42 AM
rttnews.com logoMundipharma Presents Positive Findings From Flutiform Study - Quick Facts
www.rttnews.com - September 12 at 11:45 AM
morningstar.co.uk logoVectura Partner Mundipharma Presents Positive Flutiform Data At Event
www.morningstar.co.uk - September 12 at 11:45 AM
americanbankingnews.com logoInsider Buying: Vectura Group PLC (VEC) Insider Buys 158 Shares of Stock
www.americanbankingnews.com - September 12 at 4:22 AM
americanbankingnews.com logoVectura Group PLC (VEC) Receives "Hold" Rating from Peel Hunt
www.americanbankingnews.com - September 10 at 10:44 PM
americanbankingnews.com logoVectura Group PLC (VEC) Receives "Buy" Rating from Numis Securities Ltd
www.americanbankingnews.com - September 10 at 10:50 AM
morningstar.co.uk logoDIRECTOR DEALINGS: Vectura CEO Buys Shares After Loss
www.morningstar.co.uk - September 8 at 9:57 AM
americanbankingnews.com logoVectura Group PLC (VEC) Insider Andrew Derodra Purchases 82,000 Shares
www.americanbankingnews.com - September 7 at 1:26 PM
rttnews.com logoVectura H1 Loss Widens; Announces VR410 Deal With Pulmatrix - Quick Facts
www.rttnews.com - September 7 at 10:43 AM
seekingalpha.com logoVectura Group plc 2017 Q2 - Results - Earnings Call Slides
seekingalpha.com - September 7 at 10:43 AM
prnewswire.com logoPulmatrix Licenses Inhaled COPD Drug PUR0200 to Vectura Group plc - PR Newswire (press release)
www.prnewswire.com - September 7 at 10:43 AM
finance.yahoo.com logoEdited Transcript of VEC.L earnings conference call or presentation 6-Sep-17 8:30am GMT
finance.yahoo.com - September 7 at 10:43 AM
reuters.com logoUK Stocks-Factors to watch on Sept 6 - Reuters
www.reuters.com - September 6 at 9:51 AM
americanbankingnews.com logoVectura Group PLC (VEC) Given Average Recommendation of "Buy" by Analysts
www.americanbankingnews.com - August 22 at 10:44 PM
americanbankingnews.com logoVectura Group PLC (VEC) Given "Hold" Rating at Peel Hunt
www.americanbankingnews.com - August 22 at 12:56 AM
americanbankingnews.com logoShore Capital Reiterates "Buy" Rating for Vectura Group PLC (VEC)
www.americanbankingnews.com - August 21 at 11:38 PM
morningstar.co.uk logoEXTRA: Hikma Shares Hit Four-Year Low As It Trims Guidance Once Again
www.morningstar.co.uk - August 17 at 8:58 AM
rttnews.com logoVectura's AKITA Nebuliser To Be Used By Dynavax For Lung Cancer Programme
www.rttnews.com - August 17 at 8:58 AM
americanbankingnews.com logoInsider Buying: Vectura Group PLC (VEC) Insider Purchases 135 Shares of Stock
www.americanbankingnews.com - August 7 at 1:20 PM
marketwatch.com logoSolid Dosage Forms Will Remain Preferred in the Global Oral Controlled Release Drug Delivery Technology Market - MarketWatch
www.marketwatch.com - August 2 at 8:27 AM
americanbankingnews.com logoVectura Group PLC (LON:VEC) Given Average Recommendation of "Buy" by Analysts
www.americanbankingnews.com - July 28 at 10:44 PM
americanbankingnews.com logoVectura Group PLC (VEC) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - July 3 at 10:40 PM
americanbankingnews.com logoPeel Hunt Reiterates "Hold" Rating for Vectura Group PLC (LON:VEC)
www.americanbankingnews.com - July 2 at 7:46 AM
americanbankingnews.com logoVectura Group PLC (LON:VEC) Earns Hold Rating from N+1 Singer
www.americanbankingnews.com - July 2 at 7:14 AM
morningstar.co.uk logoVectura Signs Deal With Novartis For Generic US Inhaled Therapy
www.morningstar.co.uk - June 30 at 2:10 AM
reuters.com logoBRIEF-Zhejiang Hisun Pharmaceutical receives GMP certificate - Reuters
www.reuters.com - June 29 at 7:45 AM
globenewswire.com logoVectura Group plc: New development and licence agreement for a US inhaled generic (VR2081) - GlobeNewswire (press release)
globenewswire.com - June 29 at 7:45 AM
businesswire.com logoPalladio Biosciences Announces Appointment of Frank C. Condella, Jr. to Board of Directors
www.businesswire.com - June 12 at 7:57 PM
nasdaq.com logoVectura Presents Positive Phase I Clinical Study Data For Inhaled Biologic VR942
www.nasdaq.com - May 22 at 7:34 PM
reuters.com logoBRIEF-Vectura says to present positive phase I data for VR942
www.reuters.com - May 22 at 7:34 PM
morningstar.co.uk logoVectura Reaches EUR5 Million Milestone After First FOX Launch
www.morningstar.co.uk - April 7 at 6:21 PM
seekingalpha.com logoVectura Group plc 2016 Q4 - Results - Earnings Call Slides
seekingalpha.com - March 22 at 5:40 AM
rttnews.com logoVectura 9-month Adj. Proforma EBITDA Up 57.4% - Quick Facts
www.rttnews.com - March 21 at 9:39 AM
biz.yahoo.com logoFull Year 2017 Vectura Group PLC Earnings Release - Before Market Open
biz.yahoo.com - March 21 at 9:39 AM
uk.finance.yahoo.com logo2 shares with explosive long-term growth potential
uk.finance.yahoo.com - March 21 at 9:39 AM
morningstar.co.uk logoVectura Chief Operations Officer Of US Phillips To Step Down In May
www.morningstar.co.uk - March 6 at 11:46 AM
morningstar.co.uk logoLiDCO Makes New Appointments As Chairman, Finance Director Step Down
www.morningstar.co.uk - March 1 at 9:03 AM
finanznachrichten.de logoNanobiotechnology - Global Strategic Business Report 2015-2022 - Demand for Novel Products to Push Up Growth - Research and Markets
www.finanznachrichten.de - February 17 at 5:01 PM
uk.finance.yahoo.com logo3 growth stocks I’d buy right now
uk.finance.yahoo.com - February 14 at 6:56 AM
rttnews.com logoVectura Receives IND Approval From FDA For Phase 1 Trial With VR647
www.rttnews.com - January 25 at 8:17 AM
reuters.com logoBRIEF-Vectura gets $5 mln after an inhaling device hits sales milestone
www.reuters.com - January 25 at 8:17 AM

Social

Social activity is not available for this stock.

Chart

Vectura Group PLC (VEC) Chart for Friday, October, 20, 2017

This page was last updated on 10/20/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.